Vaccines for epidemic infections and the role of CEPI
The author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2017-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2017.1306615 |
| _version_ | 1797677594073628672 |
|---|---|
| author | Stanley A. Plotkin |
| author_facet | Stanley A. Plotkin |
| author_sort | Stanley A. Plotkin |
| collection | DOAJ |
| description | The author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term. |
| first_indexed | 2024-03-11T22:47:31Z |
| format | Article |
| id | doaj.art-1b00f64c7f68484693e82820769ad96f |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:47:31Z |
| publishDate | 2017-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-1b00f64c7f68484693e82820769ad96f2023-09-22T08:17:49ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2017-12-0113122755276210.1080/21645515.2017.13066151306615Vaccines for epidemic infections and the role of CEPIStanley A. Plotkin0University of PennsylvaniaThe author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term.http://dx.doi.org/10.1080/21645515.2017.1306615chikungunyaebolacommercializationdevelopmentemerging infectionsfield deliveryinfectious diseaselassamersnipah |
| spellingShingle | Stanley A. Plotkin Vaccines for epidemic infections and the role of CEPI Human Vaccines & Immunotherapeutics chikungunya ebola commercialization development emerging infections field delivery infectious disease lassa mers nipah |
| title | Vaccines for epidemic infections and the role of CEPI |
| title_full | Vaccines for epidemic infections and the role of CEPI |
| title_fullStr | Vaccines for epidemic infections and the role of CEPI |
| title_full_unstemmed | Vaccines for epidemic infections and the role of CEPI |
| title_short | Vaccines for epidemic infections and the role of CEPI |
| title_sort | vaccines for epidemic infections and the role of cepi |
| topic | chikungunya ebola commercialization development emerging infections field delivery infectious disease lassa mers nipah |
| url | http://dx.doi.org/10.1080/21645515.2017.1306615 |
| work_keys_str_mv | AT stanleyaplotkin vaccinesforepidemicinfectionsandtheroleofcepi |